Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma.
Saved in:
| Title: | Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma. |
|---|---|
| Authors: | Xing, Hui1,2 (AUTHOR), Gao, Mengshi1,2 (AUTHOR), Wang, Yuxiang1 (AUTHOR), Zhang, Xu1,2 (AUTHOR), Shi, Jiajie1 (AUTHOR), Wang, Xiang1 (AUTHOR), Liu, Xueling1 (AUTHOR), Ma, Qingyang3 (AUTHOR), Kong, Xiangyin3 (AUTHOR), Yang, Chunhao4 (AUTHOR), Ding, Jian2,5 (AUTHOR) jding@simm.ac.cn, Meng, Linghua1,2 (AUTHOR) lhmeng@simm.ac.cn |
| Source: | Clinical & Translational Medicine. May2022, Vol. 12 Issue 5, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
